LAVAL,
QC, June 21, 2022 /PRNewswire/ -- Bausch
Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the
"Company") today announced the Company is providing a presentation
on its business during the Company's Annual Meeting of Shareholders
on June 21, 2022. The presentation
will be available on the Investor Relations section of the Bausch
Health website. The Company has filed a Form 8-K this morning,
annexing this presentation.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global
diversified pharmaceutical company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of products primarily in
gastroenterology, hepatology, neurology, dermatology, international
pharmaceuticals and eye health, through our approximately 90%
ownership of Bausch + Lomb Corporation. With our leading durable
brands, we are delivering on our commitments as we build an
innovative company dedicated to advancing global health. For more
information, visit www.bauschhealth.com and connect with us on
Twitter and LinkedIn.
|
Investor
Contact:
|
Media Contact:
|
|
Christina
Cheng
|
Lainie
Keller
|
|
christina.cheng@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
|
(514)
856-3855
|
(908)
927-1198
|
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bausch-health-issues-form-8-k-for-2022-annual-meeting-of-shareholders-presentation-301571550.html
SOURCE Bausch Health Companies Inc.